Pfizer says booster shot restores full COVID protection
A booster was shown to be 95.6% effective against symptomatic COVID in a Pfizer Inc. and BioNTech study.
A booster was shown to be 95.6% effective against symptomatic COVID in a Pfizer Inc. and BioNTech study.